Osteoblastic bone metastases in breast cancer: is not seeing believing?

被引:6
作者
Fogelman, I [1 ]
机构
[1] Guys Kings & St Thomas Sch Med, Dept Nucl Med, London SE1 9RT, England
关键词
D O I
10.1007/s00259-005-1869-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1250 / 1252
页数:3
相关论文
共 15 条
[1]   False negative F-18FDG PET/CT in nonsmall cell lung cancer bone metastases [J].
An, YS ;
Yoon, DK ;
Lee, MH ;
Joh, CW ;
Yoon, SN .
CLINICAL NUCLEAR MEDICINE, 2005, 30 (03) :203-204
[2]   Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer [J].
Bury, T ;
Barreto, A ;
Daenen, F ;
Barthelemy, N ;
Ghaye, B ;
Rigo, P .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) :1244-1247
[3]   Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer [J].
Cheran, SK ;
Herndon, JE ;
Patz, EF .
LUNG CANCER, 2004, 44 (03) :317-325
[4]   Detection of bone metastases in breast cancer by 18FDG PET:: Differing metabolic activity in osteoblastic and osteolytic lesions [J].
Cook, GJ ;
Houston, S ;
Rubens, R ;
Maisey, MN ;
Fogelman, I .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3375-3379
[5]  
Durie BGM, 2002, J NUCL MED, V43, P1457
[6]  
Durski, 2000, Clin Positron Imaging, V3, P97, DOI 10.1016/S1095-0397(00)00048-0
[7]   F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma - A comparison to conventional imaging [J].
Gallowitsch, HJ ;
Kresnik, E ;
Gasser, J ;
Kumnig, G ;
Igerc, I ;
Mikosch, P ;
Lind, P .
INVESTIGATIVE RADIOLOGY, 2003, 38 (05) :250-256
[8]  
Israel O, 2004, J NUCL MED, V45, P2045
[9]   Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma [J].
Kang, DE ;
White, RL ;
Zuger, JH ;
Sasser, HC ;
Teigland, CM .
JOURNAL OF UROLOGY, 2004, 171 (05) :1806-1809
[10]  
Moog F, 1999, J NUCL MED, V40, P1407